- Home
- INM vs MFC Comparison
INM vs MFC Comparison
Compare INM & MFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- MFC
- Stock Information
- Founded
- INM 1981
- MFC 1887
- Country
- INM Canada
- MFC Canada
- Employees
- INM N/A
- MFC N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- MFC Life Insurance
- Sector
- INM Health Care
- MFC Finance
- Exchange
- INM Nasdaq
- MFC Nasdaq
- Market Cap
- INM 3.2M
- MFC 49.3B
- IPO Year
- INM N/A
- MFC 1999
- Fundamental
- Price
- INM $2.98
- MFC $30.14
- Analyst Decision
- INM
- MFC Strong Buy
- Analyst Count
- INM 0
- MFC 2
- Target Price
- INM N/A
- MFC $45.50
- AVG Volume (30 Days)
- INM 55.8K
- MFC 2.7M
- Earning Date
- INM 05-13-2025
- MFC 05-07-2025
- Dividend Yield
- INM N/A
- MFC 3.99%
- EPS Growth
- INM N/A
- MFC 8.81
- EPS
- INM N/A
- MFC 1.97
- Revenue
- INM $4,832,013.00
- MFC $20,844,569,236.00
- Revenue This Year
- INM N/A
- MFC $41.78
- Revenue Next Year
- INM N/A
- MFC $7.54
- P/E Ratio
- INM N/A
- MFC $15.31
- Revenue Growth
- INM N/A
- MFC 10.08
- 52 Week Low
- INM $1.72
- MFC $22.96
- 52 Week High
- INM $15.70
- MFC $33.07
- Technical
- Relative Strength Index (RSI)
- INM 60.92
- MFC 52.44
- Support Level
- INM $2.56
- MFC $28.13
- Resistance Level
- INM $3.15
- MFC $29.25
- Average True Range (ATR)
- INM 0.28
- MFC 1.24
- MACD
- INM 0.09
- MFC 0.08
- Stochastic Oscillator
- INM 88.11
- MFC 62.58
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
About MFC Manulife Financial Corporation
Manulife Financial provides life insurance, annuities, and asset management products to individuals and group customers in Canada, the United States, and Asia. Its investment management business contributes approximately 20% of its earnings and has around CAD 1.05 trillion in assets under management and administration as of the end of 2023. The US business, which primarily operates under the John Hancock brand, contributes about 27% of earnings and is mainly focused on providing insurance products for estate, business, and income protection. The Asia segment provides insurance products and insurance-based wealth accumulation products in over 11 countries and contributes around 30% of earnings. The Canadian business segment contributes approximately 23% of earnings.